Abstract:Introduction Peyronie's Disease (PD) can significantly impact sexual function. A hereditary predisposition to PD suggests that genetic variants may exist, and gene expression may modulate the penetrance of the disease. Identification of changes in epigenetic or gene expression profiles would facilitate a deeper understanding of the disease and provide insight for more targeted therapies. Objective Our objective is to determine if predisposition to PD is correlated with epigenetic variations and/or gene expression changes, as indicated by DNA methylation assessment and RNA sequencing. Methods Penile tunica albuginea samples were obtained from men with PD undergoing penile prosthesis placement. Penile sample from these men were not from fibrotic plaques. Control samples were collected from men with erectile dysfunction (ED) without PD undergoing penile prosthesis placement. DNA methylation analyses were performed on homogenized penile tissue samples via an Illumina Human MethylationEPIC BeadChip v2 array. Using the minfi package in R, beta values were produced for all 936,990 CpG sites for each sample and SWAN normalization was applied. Differentially methylated regions (DMR) were found via USEQ with a threshold Wilcoxon FDR score of 40. Gene expression levels were examined in PD and ED samples via RNA-sequencing. Gene expression data was compared against epigenetic data to determine if any epigenetics changes identified affected gene expression profiles. Results A total of 24 tissue samples were collected: 12 ED and 12 PD. USEQ yielded 36 total DMRs with a FDR score of 40 or greater (p-value<0.0001). Of these 36 DMRs, a Stanford GREAT analysis revealed 60 total gene-region associations and five implicated biological processes: anterior/posterior pattern specification, chordate embryonic development, embryo development (ending in birth or egg hatching), somitogenesis, and pattern specification process. Furthermore, differential gene expression analysis identified 76 genes with significant expression changes between PD and ED groups, of which 17 genes were upregulated while 59 were downregulated. Long noncoding RNAs and the keratocan gene showed notable expression differences between PD and ED groups. GO enrichment analysis revealed significant terms related to DNA binding and protein binding. None of the differentially regulated genes overlapped with identified DMRs. Conclusions This study identified distinct gene expression and DNA methylation patterns between PD and ED groups, despite PD samples not being taken from plaque regions. Upregulated genes in PD included long noncoding RNAs and the keratocan gene, suggesting their involvement in disease pathogenesis. Long noncoding RNA overexpression may serve a regulatory function in gene expression or cell processes while overexpression of the keratocan gene may promote collagen accumulation and remodeling, leading to fibrous plaque formation in the affected area. Likewise, DMRs and their region-gene associations suggest a role in early embryonic development for pathogenesis. Although RNA-seq did not indicate any significant differentially expressed genes that matched with gene-region associations correlated with DMRs, the significance and quantity of DMRs between ED and PD sample groups is indicative of affected biological processes that manifest in distinct pathophysiologies. Further research is needed to investigate if differentially regulated genes exist in DMRs that exhibited changes but did not meet the criteria threshold for inclusion here. Disclosure Any of the authors act as a consultant, employee or shareholder of an industry for: Paterna bio, Firmtech, Turtle health, Maximus, Carrot, Contraline, endo pharmaceuticals, inherent biosciences, techfields inc, macro trials, alto neurosciences, curebase, vivify medical.

Marfan's syndrome is associated with a greater risk of Peyronie's disease: a case-control study of the TriNetX database

The impact of Marfan syndrome and Ehlers-Danlos syndrome on the risk of penile fracture in patients between 18 and 45 years

(197) The Impact of Connective Tissue Disorders on Rates of Penile Fracture and Peyronie’s Disease

(150) Erectile Dysfunction and Peyronie’s Disease Diagnosis Rates After Penile Fracture – A Retrospective Claims Database Cohort Analysis

(059) Epigenetic Profiles of Men with Peyronie's Disease

When fibrosis intersect: Association and risk factors between Peyronie's and Dupuytren's diseases

(278) Peyronie's Disease Among Men Who Have Sex With Men: Perceptions, Characteristics, and Psychosocial factors

(060) Epigenetic and Gene Expression Profiles in Non-Plaque Tissues from Men with Peyronie's Disease

(257) Cystoscopy And Its Potential Association With Peyronie'S Disease: A Retrospective Cohort Study

Aortic Dimensions, Biophysical Properties, and Plasma Biomarkers in Children and Adults with Marfan or Loeys-Dietz Syndrome

Clinical Presentation of Peyronie's Disease: A Retrospective Study of 564 Cases

Early-onset and uncontrolled diabetes mellitus factors correlate with complications of Peyronie’s disease

Marfan Syndrome: Whole-Exome Sequencing Reveals De Novo Mutations, Second Gene and Genotype–phenotype Correlations in the Chinese Population

Increased Rate of Complications Following Total Knee Arthroplasty in Patients Who Have Marfan Syndrome

(245) Surveying the Genomic Landscape of Peyronie's Disease: A Study of 22 Cases

Marfan Syndrome: Enhanced Diagnostic Tools and Follow-up Management Strategies

Association of ocular manifestations of Marfan syndrome with cardiovascular complications

Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis

(135) Systematic Review on the Association of Peyronie's Disease Development and Severity to Testosterone Level: Do we Have Enough Data?

Evaluation of the clinical features of an outpatient cohort with Marfan syndrome

(397) Investigating the Psychological Bother and Depression Among Gay Men with Peyronie's Disease